First Time Loading...

Gilead Sciences Inc
NASDAQ:GILD

Watchlist Manager
Gilead Sciences Inc Logo
Gilead Sciences Inc
NASDAQ:GILD
Watchlist
Price: 64.27 USD 0.3% Market Closed
Updated: Jun 1, 2024

Gilead Sciences Inc
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Gilead Sciences Inc
Current Portion of Long-Term Debt Peer Comparison

Comparables:
ABBV
AMGN
MRNA
VRTX
REGN

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Gilead Sciences Inc
NASDAQ:GILD
Current Portion of Long-Term Debt
$3.7B
CAGR 3-Years
18%
CAGR 5-Years
8%
CAGR 10-Years
7%
Abbvie Inc
NYSE:ABBV
Current Portion of Long-Term Debt
$10.2B
CAGR 3-Years
-3%
CAGR 5-Years
45%
CAGR 10-Years
88%
Amgen Inc
NASDAQ:AMGN
Current Portion of Long-Term Debt
$4B
CAGR 3-Years
37%
CAGR 5-Years
1%
CAGR 10-Years
5%
Moderna Inc
NASDAQ:MRNA
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Current Portion of Long-Term Debt
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Gilead Sciences Inc's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
3.7B USD

Based on the financial report for Mar 31, 2024, Gilead Sciences Inc's Current Portion of Long-Term Debt amounts to 3.7B USD.

What is Gilead Sciences Inc's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 10Y
7%

Over the last year, the Current Portion of Long-Term Debt growth was 61%. The average annual Current Portion of Long-Term Debt growth rates for Gilead Sciences Inc have been 18% over the past three years , 8% over the past five years , and 7% over the past ten years .